HealthDay on MSN
Drugs found to reduce advanced prostate cancer death rate
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...
The Brighterside of News on MSN
New drug combo cuts risk of death for men with prostate cancer by 40%
Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...
Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients ...
In hormone-sensitive prostate cancer, an alternative dosing of docetaxel plus Nubeqa and ADT was associated with improvements in side effect rates.
Health and Me on MSN
This FDA-Approved Drug Combo Could Reduce Risk Of Prostate Cancer Deaths By 40%
Researchers have been working on ways to improve prostate cancer diagnosis and deaths for years. Being one of the most common ...
Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...
Local organizations are partnering to transcend traditional health care and improve outcomes across the community. Five years ago, Hospital to Housing, an initiative from BJC HealthCare, was created ...
Former President Joe Biden completed a round of radiation therapy at a Penn Medicine cancer center in Philadelphia Monday as ...
Former President and Penn professor Joe Biden recently completed a round of radiation therapy to treat prostate cancer at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback